Jazz Pharmaceuticals plc — Director's Dealing 2018

Feb 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2018-02-26

Reporting Person: COZADD BRUCE C (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-26	Ordinary Shares	F	6269	$147.44	Disposed	267468	Direct
2018-02-27	Ordinary Shares	F	3638	$143.8	Disposed	263830	Direct
2018-02-28	Ordinary Shares	S	1000	$150.0	Disposed	262830	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.